This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Janet S. Wieselthier, MD; Valori Treloar, MD; Howard K. Koh, MD; Babar K. Rao, MD; A. Razzaque Ahmed, MD

Arch Dermatol. 1991;127(10):1575-1576.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

REPORT OF A CASE

A 34-year-old woman was seen in May 1988 for a progressive skin eruption on her face and trunk. Her pertinent medical history began in 1980 when she was diagnosed with systemic lupus erythematosus (SLE) after presenting with fatigue, arthralgias, leukopenia, and a positive antinuclear antibody titer of 1:250 in a homogeneous pattern. At that time, treatment with hydroxychloroquine sulfate (Plaquenil) resulted in normalization of all laboratory values and resolution of symptoms. After 2 years, hydroxychloroquine sulfate therapy was discontinued, and she was maintained symptom-free on tolmetin sodium (Tolectin) for the next several years.

In October 1987, she presented with a 6-month history of asymptomatic purple discoloration and swelling of her left upper and lower eyelids. Treatment with betamethasone valerate (Valisone) cream three times daily resulted in no improvement. Laboratory studies at that time were all within normal limits, including a negative antinuclear antibody and a normal . . . [Full Text PDF of this Article]

Author Affiliations
Boston (Mass) University School of Medicine and the Center for Blood Research, Harvard Medical School, Boston

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?